Showing posts with label Advanced Cell Technology. Show all posts
Showing posts with label Advanced Cell Technology. Show all posts

Wednesday, July 4, 2012

STEM CELLS DISCOVER GOD PARTICLE


Stem Cell Physicists Discover "God Particle"

Stem Cell scientists may have discovered  a new subatomic particle Wednesday, calling it " the God particle" - that helps explain what gives all matter in the universe size and shape.

This new sub atomic particle is the missing cornerstone of particle physics,"newly discovered subatomic particle is a boson, but he stopped just shy of claiming outright that it is the Higgs boson itself - an extremely fine distinction.  "We have a discovery. We have observed a new particle that is is a major breakthrough in Stem Cell Research" The new stem cell particle is seen as the key to understanding why matter has mass, which combines with gravity to give an object weight. The idea is much like gravity and Isaac Newton's discovery of it: Gravity was there all the time before Newton explained it. But now scientists have seen something very much like the Higgs boson and can put that knowledge to further use.

CERN's atom smasher cost $10 billion has been creating high-energy collisions of atoms to investigate dark matter, antimatter and the creation of the universe, which many theorize occurred in a massive explosion known as the Big Bang.  Scientist teams presented evidence in complicated scientific terms what was essentially extremely strong evidence of a new particle that can beused for stem cell treatments for humans some day.

Stem Cell "God particle" was coined by Nobel Prize-winning physicist physicists, as an easier way of explaining how the subatomic universe works and got started.  Stem cell sienteist have been playing God by reaching into the fabric of the universe in a way we never have done before. Some day soon we will be able to reproduce and repair every part of the human body thus eliminating Cancer, heart disease and other illnesses for ever.

Friday, May 4, 2012

STEM CELL TREATMENTS ON "THE DOCTORS"



STEM CELLS VIDEO ON "THE DOCTORS"

Stem Cell Therapy has started to hit main street as the TV show " The Doctors" featured world famous surgeon Dr. Ronald Hansen and his patient that received Stem Cell Injections Operation that helped Cure her knee and shoulder problems.

Many people suffering from Osteoarthritis of the hip & knee are getting relief and even turning back the age clock with the use of stem cells. The Centro-Schultz stem cell clinic in Denver Colorado is a world leading center for the treatment of all kinds of joint problems. The doctors take your own blood and spin out the stem cells and then extract your own bone marrow then mix it all together and re-inject the stem cell cocktail back into your hip joint gap area. After a few weeks most patients experience a huge improvement in the way the walk, exercise and move.

Stem cells are fast becoming an alternative to hip & knee replacement surgery.  A good friend of mine had problems with his hip and was scheduled for a hip replacement surgery. He went to Denver to talk with Dr. Centro about the possibility of stem cell treatments as an option for hit hip arthritis. He had the injections of his own stemm cells and is now walking, running and playing sports again. needless to say his hip replacement surgery was cancelled thanks to the advances treatments of injecting his own stem cells.

Some day Stem Cells will be used in almost every part of your body to heal, repair, cure and rejuvenate your own cells. In short with the growing science of stem cells you will be able to live forever so take good care of yourself.

Enhanced by Zemanta

Wednesday, February 22, 2012

STEM CELL CORD BLOOD

Umbilical Stem Cell Cord Blood Research

What Is Stem Cell Cord Blood?

"Stem Cell Cord Blood" refers to the umbilical cord blood found after child birth in the placenta yet still attached to the umbilical cord. Stem cell cord blood is stored by stem cell storage banks primarily for umbilical cord blood stem cell research which can be used to treat many forms of cancer causing genetic diseases that kill millions of humans every year.

Stem cell cord blood is extracted by syringing out the placenta umbilical cord during birth just before the cord blood stem cell has been cut from the baby. These baby umbilical cord stem cells are perfect for advanced umbilical cord blood stem cell storage companies and especially for American President Obama Stem Cell Research policy guidelines of the stem cell industry.

Cord cells are collected and stored because they contain high concentration of natures most potent types of Baby stem cells that are necessary to stem cell rejuvenating cells. The problem with this process of Stem cell extractions that the Placenta cord blood does not produce enough stem cells for treatments or research in Adults.

 so the placenta is more valuable method of stem cell extraction mainly because it has 100 times more high quality baby stem cell storage than adult cord blood.

Obama Umbilical Cord Stem Cell Research

U.S. President Obama formed the stem cell research council under the the Food and Drug Agency to supervise all aspects of stem cell cord blood research under the title of Human Cells, Tissues cells, and Cellular and Tissue Based Human Research Products or "FDA"

The U.S. Stem Cell Research Agency has developed a standard Code of Stem Cell conduct under Federal Regulations to provide guidelines for public and private stem cell cord blood banking companies banks.

Public and private cord blood storage banks are eligible for funding  with either the American Association of Blood Banks AABB or the Foundation for the Accreditation of Cellular Therapy.

Stem Cell Storage Companies and  baby stem cell banks can review the updated status of Stem Cell banks from U.S. government list of accredited cord blood banks or the FACT search engine of accredited cord blood banks.

 Europe, Asia and Canada are also working together to develop new stem cell laws pertaining to umbilical cord blood stem cell research and stem cell storage companies.

Tuesday, February 21, 2012

EMBRIONC STEM CELLS

English: Diagram to show how embryonic stem ce...
Image via Wikipedia

Embryonic Stem Cells

1. Stages of development generating embryonic stem cells.
Stem cells, are derived from embryos. Most embryonic stem cells are derived from embryos that develop from eggs that have been fertilized in vitro fertilization clinic and then donated for research purposes with informed consent of the donors. They are not derived from eggs fertilized in a woman's body.

2.Growing Embryonic Stem Cells

Growing cells in the laboratory is known as cell culture. Human embryonic stem cells  are generated by transferring cells from a embryo into a plastic laboratory culture dish that contains a nutrient broth known as culture medium. The cells divide and spread over the surface of the dish. The inner surface of the culture dish is typically coated with mouse embryonic skin cells that have been treated so they will not divide. This coating layer of cells is called a feeder layer. The mouse cells in the bottom of the culture dish provide the cells a sticky surface to which they can attach. Feeder cells release nutrients into the culture medium. Researchers have devised ways to grow embryonic stem cells without mouse feeder cells. This is a significant scientific advance because of the risk that viruses or other macromolecules in the mouse cells may be transmitted to the human cells.

The process of generating an embryonic stem cell line is somewhat inefficient, so lines are not produced each time cells from the  embryo are placed into a culture dish. However, if the plated cells survive, divide and multiply enough to crowd the dish, they are removed gently and plated into several fresh culture dishes. The process of re-plating  the cells is repeated many times and for many months. Each cycle of  the cells is referred to as a passage. Once the cell line is established, the original cells yield millions of embryonic stem cells. Embryonic stem cells that have proliferated in cell culture for for a prolonged period of time without differentiating,  have not developed genetic abnormalities are referred to as an embryonic stem cell line. At any stage in the process, batches of cells can be frozen and shipped to other laboratories for further culture and experimentation.

3. Embryonic Stem Cells Tests
At various points during the process of generating embryonic stem cell lines, scientists test the cells to see whether they exhibit the fundamental properties that make them embryonic stem cells. This process is called characterization.

Scientists who study human embryonic stem cells have not yet agreed on a standard battery of tests that measure the cells' fundamental properties. However, laboratories that grow human embryonic stem cell lines use several kinds of tests, including:

    Growing and sub culturing the stem cells for many months. This ensures that the cells are capable of long-term growth and self-renewal. Scientists inspect the cultures through a microscope to see that the cells look healthy and remain undifferentiated.
    Using specific techniques to determine the presence of transcription factors that are typically produced by undifferentiated cells. Two of the most important transcription factors are Nanog and Oct4. Transcription factors help turn genes on and off at the right time, which is an important part of the processes of cell differentiation and embryonic development. In this case, both Oct 4 and Nanog are associated with maintaining the stem cells in an undifferentiated state, capable of self-renewal.
    Using specific techniques to determine the presence of paricular cell surface markers that are typically produced by undifferentiated cells.
    Examining the chromosomes under a microscope. This is a method to assess whether the chromosomes are damaged or if the number of chromosomes has changed. It does not detect genetic mutations in the cells.
    Determining whether the cells can be re-grown, or subcultures, after freezing, thawing, and re-plating.
A colony of embryonic stem cells, from the H9 ...
Image via Wikipedia
 4. Human Embryonic Stem Cells
1) allowing the cells to differentiate spontaneously in cell culture
2) manipulating the cells so they will differentiate to form cells characteristic of the three germ layers; or
 3) injecting the cells into a mouse with a suppressed immune system to test for the formation of a benign tumor called a teratoma. Since the mouse’s immune system is suppressed, the injected human stem cells are not rejected by the mouse immune system and scientists can observe growth and differentiation of the human stem cells. Teratomas typically contain a mixture of many differentiated or partly differentiated cell types—an indication that the embryonic stem cells are capable of differentiating into multiple cell types.
Enhanced by Zemanta

Monday, September 26, 2011

HISTORY OF STEM CELLS

organ regeneration example from induced plurip...Image via Wikipedia STEM CELL HISTORY

  •     1908: The term "stem cell" was proposed for scientific use by the Russian histologist Alexander Maksimov (1874–1928) at congress of hematologic society in Berlin. It postulated existence of haematopoietic stem cells.
  •     1960s: Joseph Altman and Gopal Das present scientific evidence of adult neurogenesis, ongoing stem cell activity in the brain; like André Gernez, their reports contradict Cajal's "no new neurons" dogma and are largely ignored.
  •     1963: McCulloch and Till illustrate the presence of self-renewing cells in mouse bone marrow.
  •     1968: Bone marrow transplant between two siblings successfully treats SCID.
  •     1978: Haematopoietic stem cells are discovered in human cord blood.
  •     1981: Mouse embryonic stem cells are derived from the inner cell mass by scientists Martin Evans, Matthew Kaufman, and Gail R. Martin. Gail Martin is attributed for coining the term "Embryonic Stem Cell".
  •     1992: Neural stem cells are cultured in vitro as neurospheres.
  •     1997: Leukemia is shown to originate from a haematopoietic stem cell, the first direct evidence for cancer stem cells.
  •     1998: James Thomson and coworkers derive the first human embryonic stem cell line at the University of Wisconsin–Madison.
  •     1998: John Gearhart (Johns Hopkins University) extracted germ cells from fetal gonadal tissue (primordial germ cells) before developing pluripotent stem cell lines from the original extract.
  •     2000s: Several reports of adult stem cell plasticity are published.
  •     2001: Scientists at Advanced Cell Technology clone first early (four- to six-cell stage) human embryos for the purpose of generating embryonic stem cells.
  •     2003: Dr. Songtao Shi of NIH discovers new source of adult stem cells in children's primary teeth.
  •     2004–2005: Korean researcher Hwang Woo-Suk claims to have created several human embryonic stem cell lines from unfertilised human oocytes. The lines were later shown to be fabricated.
  •     2005: Researchers at Kingston University in England claim to have discovered a third category of stem cell, dubbed cord-blood-derived embryonic-like stem cells (CBEs), derived from umbilical cord blood. The group claims these cells are able to differentiate into more types of tissue than adult stem cells.
  •     2005: Researchers at UC Irvine's Reeve-Irvine Research Center are able to partially restore the ability of rats with paralyzed spines to walk through the injection of human neural stem cells.
  •     August 2006: Mouse Induced pluripotent stem cells: the journal Cell publishes Kazutoshi Takahashi and Shinya Yamanaka.
  •     October 2006: Scientists at Newcastle University in England create the first ever artificial liver cells using umbilical cord blood stem cells
  •     January 2007: Scientists at Wake Forest University led by Dr. Anthony Atala and Harvard University report discovery of a new type of stem cell in amniotic fluid.This may potentially provide an alternative to embryonic stem cells for use in research and therapy.
  •     June 2007: Research reported by three different groups shows that normal skin cells can be reprogrammed to an embryonic state in mice. In the same month, scientist Shoukhrat Mitalipov reports the first successful creation of a primate stem cell line through somatic cell nuclear transfer
  •     October 2007: Mario Capecchi, Martin Evans, and Oliver Smithies win the 2007 Nobel Prize for Physiology or Medicine for their work on embryonic stem cells from mice using gene targeting strategies producing genetically engineered mice (known as knockout mice) for gene research.
  •     November 2007: Human induced pluripotent stem cells: Two similar papers released by their respective journals prior to formal publication: in Cell by Kazutoshi Takahashi and Shinya Yamanaka, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", and in Science by Junying Yu, et al., from the research group of James Thomson, "Induced pluripotent stem cell lines derived from human somatic cells": pluripotent stem cells generated from mature human fibroblasts. It is possible now to produce a stem cell from almost any other human cell instead of using embryos as needed previously, albeit the risk of tumorigenesis due to c-myc and retroviral gene transfer remains to be determined.
  •     January 2008: Robert Lanza and colleagues at Advanced Cell Technology and UCSF create the first human embryonic stem cells without destruction of the embryo
  •     January 2008: Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts
  •     February 2008: Generation of pluripotent stem cells from adult mouse liver and stomach: these iPS cells seem to be more similar to embryonic stem cells than the previously developed iPS cells and not tumorigenic, moreover genes that are required for iPS cells do not need to be inserted into specific sites, which encourages the development of non-viral reprogramming techniques.
  •     March 2008-The first published study of successful cartilage regeneration in the human knee using autologous adult mesenchymal stem cells is published by clinicians from Regenerative Sciences
  •     October 2008: Sabine Conrad and colleagues at Tübingen, Germany generate pluripotent stem cells from spermatogonial cells of adult human testis by culturing the cells in vitro under leukemia inhibitory factor (LIF) supplementation.
  •     30 October 2008: Embryonic-like stem cells from a single human hair.
  •     1 March 2009: Andras Nagy, Keisuke Kaji, et al. discover a way to produce embryonic-like stem cells from normal adult cells by using a novel "wrapping" procedure to deliver specific genes to adult cells to reprogram them into stem cells without the risks of using a virus to make the change. The use of electroporation is said to allow for the temporary insertion of genes into the cell.[81][82][83][84]
  •     28 May 2009 Kim et al. announced that they had devised a way to manipulate skin cells to create patient specific "induced pluripotent stem cells" (iPS), claiming it to be the 'ultimate stem cell solution'.
  •     11 October 2010 First trial of embryonic stem cells in humans.
  •     25 October 2010: Ishikawa et al. write in the Journal of Experimental Medicine that research shows that transplanted cells that contain their new host's nuclear DNA could still be rejected by the invidual's immune system due to foreign mitochondrial DNA. Tissues made from a person's stem cells could therefore be rejected, because mitochondrial genomes tend to accumulate mutations.
  •     2011: Israeli scientist Inbar Friedrich Ben-Nun led a team which produced the first stem cells from endangered species, a breakthrough that could save animals in danger of extinction.

From Wikipedia: Stem Cells
Enhanced by Zemanta